» Articles » PMID: 21349926

Subclinical Lung Disease, Macrocytosis, and Premature Graying in Kindreds with Telomerase (TERT) Mutations

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2011 Feb 26
PMID 21349926
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mutations in the human gene encoding the protein component of telomerase (TERT) are the most common genetic defect in patients with familial idiopathic pulmonary fibrosis (IPF). The subclinical phenotypes of asymptomatic members of these families have not been evaluated with respect to TERT mutation status or telomere length.

Methods: We measured a variety of pulmonary, blood, skin, and bone parameters for 20 subjects with heterozygous TERT mutations (carriers) and 20 family members who had not inherited a TERT mutation (noncarriers) to identify the spectrum of phenotypes associated with mutations in this gene. The two groups were matched for sex, age, and cigarette smoking. Three TERT mutation carriers had IPF (IPF carriers). The rest of the carriers were apparently healthy (asymptomatic carriers) and were compared with the noncarriers.

Results: Asymptomatic carriers exhibited significantly lower diffusing capacity of lung for carbon monoxide (Dlco), impaired recruitment of Dlco with exercise, radiographic signs of lung fibrosis, and increased fractional lung tissue volume quantified by high-resolution chest CT scan than noncarriers. RBC and platelet counts were significantly lower, and the mean corpuscular volume and mean corpuscular hemoglobin concentration were significantly higher in carriers than in noncarriers. Carriers reported significantly earlier graying of hair than noncarriers. TERT mutation status is more accurately predicted by short telomere lengths than any of these measured phenotypes.

Conclusions: TERT mutation carriers exhibit early preclinical signs of lung fibrosis, bone marrow dysfunction, and premature graying. These clinical features and short telomere lengths characterize patients with germline TERT mutations.

Citing Articles

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey.

Moen E, Prior T, Kreuter M, Wuyts W, Molina-Molina M, Wijsenbeek M BMC Pulm Med. 2025; 25(1):59.

PMID: 39901224 PMC: 11792556. DOI: 10.1186/s12890-025-03532-0.


Liver disease and transplantation in telomere biology disorders: An international multicenter cohort.

Wang Y, Kaj-Carbaidwala B, Lane A, Agarwal S, Beier F, Bertuch A Hepatol Commun. 2024; 8(7).

PMID: 38896081 PMC: 11186813. DOI: 10.1097/HC9.0000000000000462.


Diagnosis of interstitial lung diseases: from Averill A. Liebow to artificial intelligence.

Yi E, Wawryko P, Ryu J J Pathol Transl Med. 2024; 58(1):1-11.

PMID: 38229429 PMC: 10792278. DOI: 10.4132/jptm.2023.11.17.


Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders.

Del Valle K, Carmona E Curr Hematol Malig Rep. 2023; 19(6):285-292.

PMID: 38159192 PMC: 11568037. DOI: 10.1007/s11899-023-00720-9.


Genetic and environmental factors in interstitial lung diseases: current and future perspectives on early diagnosis of high-risk cohorts.

Stanel S, Callum J, Rivera-Ortega P Front Med (Lausanne). 2023; 10:1232655.

PMID: 37601795 PMC: 10435297. DOI: 10.3389/fmed.2023.1232655.


References
1.
Menke D, Hook C . A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am. 1992; 76(3):581-97. DOI: 10.1016/s0025-7125(16)30341-8. View

2.
Roughton F, Forster R . Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957; 11(2):290-302. DOI: 10.1152/jappl.1957.11.2.290. View

3.
Hsia C, McBrayer D, Ramanathan M . Reference values of pulmonary diffusing capacity during exercise by a rebreathing technique. Am J Respir Crit Care Med. 1995; 152(2):658-65. DOI: 10.1164/ajrccm.152.2.7633723. View

4.
Chance W, Rhee C, Yilmaz C, Dane D, Pruneda M, Raskin P . Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008; 31(8):1596-601. PMC: 2494655. DOI: 10.2337/dc07-2323. View

5.
Burrows B, Kasik J, Niden A, Barclay W . Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis. 1961; 84:789-806. DOI: 10.1164/arrd.1961.84.6.789. View